Sandro Ripa

985 total citations
54 papers, 807 citations indexed

About

Sandro Ripa is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Sandro Ripa has authored 54 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 23 papers in Infectious Diseases and 20 papers in Epidemiology. Recurrent topics in Sandro Ripa's work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Antimicrobial Resistance in Staphylococcus (19 papers) and Streptococcal Infections and Treatments (13 papers). Sandro Ripa is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (23 papers), Antimicrobial Resistance in Staphylococcus (19 papers) and Streptococcal Infections and Treatments (13 papers). Sandro Ripa collaborates with scholars based in Italy, Czechia and United States. Sandro Ripa's co-authors include Manuela Prenna, Luca A. Vitali, Pietro E. Varaldo, Luigi Ferrante, Claudia Zampaloni, Dezemona Petrelli, Fiorenzo Mignini, Bruna Facinelli, Gloria Magi and Maria Pia Montanari and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Sandro Ripa

52 papers receiving 771 citations

Peers

Sandro Ripa

PHEOH

EPIDE

PHARM

Manuela Prenna Italy

J. P. Maskell United Kingdom

M E Erwin United States

Linda A. Miller United States

Laura Mandel United States

Michael A. Pfaller United States

S. M. Hussain Qadri Saudi Arabia

Sharon A. Crawford United States

M. Leticia McElmeel United States

P. Van der Auwera Belgium

Manuela Prenna Italy

Sandro Ripa

330 ×0.8

192 ×0.7

PHEOH

201 ×0.8

EPIDE

171 ×1.1

115 ×0.8

PHARM

Citations per year, relative to Sandro Ripa Sandro Ripa (= 1×) peers Manuela Prenna

Countries citing papers authored by Sandro Ripa

Since Specialization

Citations

This map shows the geographic impact of Sandro Ripa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Ripa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Ripa more than expected).

Fields of papers citing papers by Sandro Ripa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandro Ripa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Ripa. The network helps show where Sandro Ripa may publish in the future.

Co-authorship network of co-authors of Sandro Ripa

This figure shows the co-authorship network connecting the top 25 collaborators of Sandro Ripa. A scholar is included among the top collaborators of Sandro Ripa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandro Ripa. Sandro Ripa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ambrosi, Cecilia, et al.. (2012). Outer Membrane Protein A (OmpA): A New Player in Shigella flexneri Protrusion Formation and Inter-Cellular Spreading. PLoS ONE. 7(11). e49625–e49625. 35 indexed citations

Petrelli, Dezemona, Elisabetta Bolli, Maurizio Falconi, et al.. (2011). A study on erm(B)-mediated MLS resistance in Streptococcus pyogenes clinical isolates. Diagnostic Microbiology and Infectious Disease. 70(3). 387–394. 1 indexed citations

Pasquantonio, Guido, Claudio Greco, Manuela Prenna, et al.. (2008). Antibacterial Activity and Anti-Biofilm Effect of Chitosan against Strains of Streptococcus Mutans Isolated in Dental Plaque. International Journal of Immunopathology and Pharmacology. 21(4). 993–997. 37 indexed citations

Petrelli, Dezemona, Claudia Zampaloni, Simonetta D’Ercole, et al.. (2006). Analysis of different genetic traits and their association with biofilm formation in Staphylococcus epidermidis isolates from central venous catheter infections. European Journal of Clinical Microbiology & Infectious Diseases. 25(12). 773–781. 43 indexed citations

Drago, Lorenzo, Elena De Vecchi, L. Nicola, et al.. (2005). In VitroSelection of Resistance to Clarithromycin inStreptococcus pneumoniaeClinical Isolates. Journal of Chemotherapy. 17(2). 161–168. 3 indexed citations

Petrelli, Dezemona, Manuela Prenna, Claudia Zampaloni, et al.. (2005). Distribution of mef(A)-containing genetic elements in erythromycin-resistant isolates of Streptococcus pyogenes from Italy. Clinical Microbiology and Infection. 11(11). 927–930. 12 indexed citations

Zampaloni, Claudia, et al.. (2002). Erythromycin Resistance in Italian Isolates of Streptococcus pyogenes and Correlations with Pulsed-Field Gel Electrophoresis Analysis. Microbial Drug Resistance. 8(1). 39–44. 13 indexed citations

Ripa, Sandro, Claudia Zampaloni, Luca A. Vitali, et al.. (2001). Sma I Macrorestriction Analysis of Italian Isolates of Erythromycin-Resistant Streptococcus pyogenes and Correlations with Macrolide-Resistance Phenotypes. Microbial Drug Resistance. 7(1). 65–71. 39 indexed citations

Falconi, Maurizio, et al.. (2000). Plasmid curing effect of trovafloxacin. FEMS Microbiology Letters. 184(2). 297–302. 14 indexed citations

10.

Varaldo, Pietro E., Eugenio A. Debbia, Giuseppe Nicoletti, et al.. (1999). Nationwide Survey in Italy of Treatment ofStreptococcus pyogenesPharyngitis in Children: Influence of Macrolide Resistance on Clinical and Microbiological Outcomes. Clinical Infectious Diseases. 29(4). 869–873. 65 indexed citations

11.

Montanari, Maria Pia, Manuela Prenna, Marina Mingoia, Sandro Ripa, & Pietro E. Varaldo. (1998). In vitro Antibacterial Activity of Trovafloxacin and Five Other Fluoroquinolones. Chemotherapy. 44(2). 85–93. 14 indexed citations

12.

Prenna, Manuela, Maria Pia Montanari, Marina Mingoia, et al.. (1998). Antistaphylococcal and Antistreptococcal Killing Kinetics of Ciprofloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin. European Journal of Clinical Microbiology & Infectious Diseases. 17(11). 816–819. 4 indexed citations

13.

Facinelli, Bruna, Gloria Magi, Manuela Prenna, Sandro Ripa, & Pietro E. Varaldo. (1997). In vitro extracellular and intracellular activity of two newer and two earlier fluoroquinolones againstListeria monocytogenes. European Journal of Clinical Microbiology & Infectious Diseases. 16(11). 827–833. 15 indexed citations

14.

Ripa, Sandro, Luigi Ferrante, & Manuela Prenna. (1996). A Linear Model for the Pharmacokinetics of Azithromycin in Healthy Volunteers. Chemotherapy. 42(6). 402–409. 14 indexed citations

15.

Chmara, Henryk, Sandro Ripa, Fiorenzo Mignini, & Edward Borowski. (1991). Bacteriolytic effect of teicoplanin. Journal of General Microbiology. 137(4). 913–919. 11 indexed citations

16.

Ripa, Sandro, Luigi Ferrante, & Manuela Prenna. (1990). Pharmacokinetics of Sulbactam/Ampicillin in Humans after Intravenous and Intramuscular Injection. Chemotherapy. 36(3). 185–192. 16 indexed citations

17.

Varaldo, Pietro E., Sandro Ripa, Giuseppe Nicoletti, et al.. (1990). In vitro Activity of Sulbactam/Ampicillin against Ampicillin-Resistant, β-Lactamase-Producing Bacteria Isolated in Italian Hospitals. Chemotherapy. 36(2). 141–146. 1 indexed citations

18.

Ripa, Sandro, et al.. (1988). Pharmacokinetics of Bacampicillin Using a Compartment Model with Zero-Order Absorption. Chemotherapy. 34(2). 85–89. 1 indexed citations

19.

Ripa, Sandro, et al.. (1988). Pharmacokinetics of Teicoplanin. Chemotherapy. 34(3). 178–184. 11 indexed citations

20.

Pannelli, F, Sandro Ripa, Fiorenzo Mignini, & Manuela Prenna. (1985). [Production of coagulase and thermonuclease in 366 strains of staphylococci belonging to different lyogroups].. PubMed. 64(2). 115–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact